Terrie Curran, President and Chief Executive at Phathom Pharmaceuticals, Inc. (PHAT), sold 33,702 shares at $9.11 ($307K) on 2024-03-22, disclosed to the SEC on 2024-03-26.
Open-market sale of $307k PHAT by President and Chief Executive. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.11 | 16,851 | $154K | 50.0% |
| 2 | $9.11 | 16,851 | $154K | 50.0% |
| Total | $9.11 avg | 33,702 | $307K | 100% |
| Filing → |
| PHAT | SELL | 2025-01-23 | $252K | — | Filing → |
| ARQT | SELL | 2024-11-13 | $189K | — | Filing → |
| PHAT | SELL | 2024-07-17 | $793K | — | Filing → |